A Better Newspaper

## Overview Uganda has closed its border with the Democratic Republic of Congo "with immediate effect" as suspected Ebola cases surge toward 1,000 in the DRC, involving a rare Bundibugyo strain for which there are no approved medicines or vaccines (SCMP, May 2026). Cases have also begun emerging inside Uganda itself (SCMP, May 2026). ## The Bundibugyo Strain The Bundibugyo species of Ebola is distinct from the more commonly encountered Zaire strain that spurred the development of approved vaccines such as rVSV-ZEBOV. There are currently no approved therapeutics or vaccines for Bundibugyo, significantly complicating the public health response (SCMP, May 2026). ## Uganda's Border Closure Uganda's decision to close the border goes against World Health Organization guidance, which generally recommends against border closures as ineffective and potentially counterproductive to outbreak response (SCMP, May 2026). The measure underscores "growing fears of contagion" in a country that has experience responding to prior Ebola outbreaks but has not previously faced Bundibugyo at this scale (SCMP, May 2026). ## Current Epidemiological Picture - Suspected cases in DRC: approaching 1,000 (SCMP, May 2026) - Cases emerging inside Uganda (SCMP, May 2026) - No approved vaccines or medicines for this strain (SCMP, May 2026) - Border with DRC closed by Ugandan authorities (SCMP, May 2026) ## Significance for Attorneys & Entrepreneurs This outbreak has several forward-looking dimensions: potential WHO emergency declarations, accelerated regulatory pathways for experimental Bundibugyo therapeutics or vaccines, supply chain disruptions in the East Africa region, travel advisories, and liability considerations for employers with staff in the affected region. The divergence between Uganda's border closure and WHO guidance may also generate international law and health governance implications.